CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 86 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,737,140 | -12.4% | 147,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,124,000 | +23930.8% | 147,000 | +20009.4% | 0.00% | – |
| Q1 2021 | $13,000 | -78.3% | 731 | -82.4% | 0.00% | – |
| Q4 2020 | $60,000 | +200.0% | 4,160 | +232.0% | 0.00% | – |
| Q3 2020 | $20,000 | -41.2% | 1,253 | -41.9% | 0.00% | – |
| Q2 2020 | $34,000 | -2.9% | 2,156 | +53.8% | 0.00% | – |
| Q4 2019 | $35,000 | +133.3% | 1,402 | +45.0% | 0.00% | – |
| Q3 2019 | $15,000 | -34.8% | 967 | +4.4% | 0.00% | – |
| Q2 2019 | $23,000 | +2200.0% | 926 | +1647.2% | 0.00% | – |
| Q1 2019 | $1,000 | -66.7% | 53 | -45.4% | 0.00% | – |
| Q4 2018 | $3,000 | +200.0% | 97 | +102.1% | 0.00% | – |
| Q3 2018 | $1,000 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
| Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
| Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
| 5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
| First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
| BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
| BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
| Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |